Articles in Scholarly Journals [Incomplete List]

1. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome
   Cancer, vol. 109, no. 10, pp. 2016–2024, 2007
2. A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder
   World Journal of Urology, vol. 25, no. 3, pp. 297–302, 2007
3. Molecular Cancer, vol. 6, no. 1, p. 14, 2007
4. In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer
   Experimental and Molecular Pathology, vol. 82, no. 3, pp. 292–297, 2007
5. Epigenetics of prostate cancer: beyond DNA methylation
   Journal of Cellular and Molecular Medicine, vol. 10, no. 1, pp. 100–125, 2006
6. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma
   Endocrine Related Cancer, vol. 13, no. 3, pp. 839–849, 2006
7. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: Hypermethylation-independent mechanisms of inactivation
   European Journal of Cancer, vol. 42, no. 2, pp. 264–274, 2006
8. Relationship of NKX3.1 and MYC Gene Copy Number Ratio and DNA Hypomethylation to Prostate Carcinoma Stage
   European Urology, vol. 49, no. 1, pp. 169–175, 2006
9. L1 Retrotransposons in Human Cancers
   Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 83672, 12 pages, 2006
10. Genomic and Expression Analysis of the 3q25-q26 Amplification Unit Reveals TLOC1/SEC62 as a Probable Target Gene in Prostate Cancer
    Molecular Cancer Research, vol. 4, no. 3, pp. 169–176, 2006
11. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: A combined comparative genomic hybridization and microsatellite analysis
    Genes, Chromosomes and Cancer, vol. 45, no. 11, pp. 995–1006, 2006
12. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies
    Biochemical Pharmacology, vol. 72, no. 11, pp. 1577–1588, 2006
13. Understanding urothelial carcinoma through cancer pathways
    International Journal of Cancer, vol. 119, no. 7, pp. 1513–1518, 2006
14. Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines
    Journal of Cellular Physiology, vol. 203, no. 2, pp. 372–377, 2005
15. Multiple mechanisms downregulateCDKN1C in human bladder cancer
    International Journal of Cancer, vol. 114, no. 3, pp. 406–413, 2005
16. Application of a Modified Real-Time PCR Technique for Relative Gene Copy Number Quantification to the Determination of the Relationship between NKX3.1 Loss and MYC Gain in Prostate Cancer
    Clinical Chemistry, vol. 51, no. 3, pp. 649–652, 2005
17. Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract
    Scandinavian Journal of Gastroenterology, vol. 40, no. 1, pp. 109–111, 2005
18. Estimating cancer survival and clinical outcome based on genetic tumor progression scores
    Bioinformatics, vol. 21, no. 10, pp. 2438–2446, 2005
19. Molecular Cancer, vol. 4, no. 1, p. 16, 2005
20. Causes and consequences of DNA hypomethylation in human cancer
    Biochemistry and Cell Biology, vol. 83, no. 3, pp. 296–321, 2005
21. Qualified Promise: DNA Methylation Assays for the Detection and Classification of Human Cancers
    Journal of Biomedicine and Biotechnology, vol. 2005, no. 3, pp. 227–229, 2005
22. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation
    British Journal of Cancer, Article ID 6602030, 2004
23. Suppression of clonogenicity by mammalian Dnmt1 mediated by the PCNA-binding domain
    Biochemistry and Cell Biology, vol. 82, no. 5, pp. 589–596, 2004
24. Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines
    Oncogene, vol. 23, no. 20, Article ID 1207346, 8 pages, 2004
25. Denaturing high-performance liquid chromatography (DHPLC) as a reliable high-throughput prescreening method for aberrant promoter methylation in cancer
    Human Mutation, vol. 23, no. 6, pp. 612–620, 2004
26. Homozygous deletions ofCDKN2A caused by alternative mechanisms in various human cancer cell lines
    Genes, Chromosomes and Cancer, vol. 42, no. 1, pp. 58–67, 2004
27. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status
    Urology, vol. 63, no. 2, pp. 392–397, 2004
28. Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population
    Journal of Cancer Research and Clinical Oncology, vol. 130, no. 10, 2004
29. Transcriptional regulation of the human LINE-1 retrotransposon L1.2B
    Molecular Genetics and Genomics, vol. 270, no. 5, pp. 394–402, 2004
30. Activities of MAP-Kinase Pathways in Normal Uroepithelial Cells and Urothelial Carcinoma Cell Lines
    Experimental Cell Research, vol. 282, no. 1, pp. 48–57, 2003
31. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells
    Genes, Chromosomes and Cancer, vol. 37, no. 2, pp. 141–148, 2003
32. Association betweenNAD(P)H: Quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract
    International Journal of Cancer, vol. 107, no. 3, pp. 381–386, 2003
33. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma
    International Journal of Cancer, vol. 104, no. 5, pp. 568–578, 2003
34. Fibroblast Growth Factors and Their Receptors in Urological Cancers: Basic Research and Clinical Implications
    European Urology, vol. 43, no. 3, pp. 309–319, 2003
35. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region
    Experimental and Molecular Pathology, vol. 74, no. 3, pp. 262–266, 2003
36. E-cadherin involved in inactivation of WNT/ß-catenin signalling in urothelial carcinoma and normal urothelial cells
    British Journal of Cancer, vol. 88, no. 12, Article ID 6601031, 6 pages, 2003
37. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population
    Carcinogenesis, vol. 24, no. 5, pp. 905–909, 2003
38. Molecular biology of prostate cancer
    Molecular Human Reproduction, vol. 9, no. 8, pp. 437–448, 2003
39. p21 and p53 Immunostaining and Survival following Systemic Chemotherapy for Urothelial Cancer
    Urologia Internationalis, vol. 69, no. 3, pp. 174–180, 2002
40. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma
    Genes, Chromosomes and Cancer, vol. 35, no. 1, pp. 58–65, 2002
41. Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer
    The Prostate, vol. 50, no. 3, pp. 135–144, 2002
42. Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor ?B sites in prostatic carcinoma
    Molecular Carcinogenesis, vol. 32, no. 1, pp. 36–43, 2001
43. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder
    British Journal of Cancer, vol. 85, no. 12, Article ID 6692154, 6 pages, 2001
44. Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder
    Mutation Research/Mutation Research Genomics, vol. 458, no. 1-2, pp. 49–54, 2001
45. Cyclin-dependent kinase inhibitor ?27KIP1 is expressed preferentially in early stages of urothelial carcinoma
    Urology, vol. 56, no. 4, pp. 689–695, 2000
46. Decreased expression of p57KIP2mRNA in human bladder cancer
    British Journal of Cancer, vol. 83, no. 5, pp. 626–631, 2000
47. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma
    The Prostate, vol. 45, no. 3, pp. 225–231, 2000
48. Phenol sulphotransferase SULT 1A1 polymorphism in prostate cancer: lack of association
    Archives of Toxicology, vol. 74, no. 4-5, pp. 222–225, 2000
49. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma
    Archives of Toxicology, vol. 74, no. 9, pp. 521–526, 2000
50. Novel mutations of the von Hippel-Lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type
    International Journal of Cancer, vol. 87, no. 5, pp. 650–653, 2000
51. Loss of HNF1? function in human renal cell carcinoma: Frequent mutations in theVHL gene but not theHNF1? gene
    Molecular Carcinogenesis, vol. 24, no. 4, pp. 305–314, 1999
52. Over-expression and amplification of the c-myc gene in human urothelial carcinoma
    International Journal of Cancer, vol. 84, no. 2, pp. 169–173, 1999
53. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas
    British Journal of Cancer, vol. 80, no. 9, pp. 1312–1321, 1999
54. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate
    The Prostate, vol. 39, no. 3, pp. 166–174, 1999
55. Expression of G1S Transition Regulatory Molecules in Human Urothelial Cancer
    Cancer Science, vol. 89, no. 7, pp. 719–726, 1998
56. Predictive Value of Molecular Alterations for the Prognosis of Urothelial Carcinoma
    Cancer Detection Prevention, vol. 22, no. 5, pp. 422–429, 1998
57. Predisposition towards urolithiasis associated with the NQ01 null-allele
    Pharmacogenetics, vol. 8, no. 5, pp. 453–454, 1998
58. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies
    Pharmacogenetics, vol. 7, no. 3, pp. 235–239, 1997
59. Adjacent guanines as preferred sites for strand breaks in plasmid DNA irradiated with 193 nm and 248 nm UV laser light
    Journal of Photochemistry and Photobiology B: Biology, vol. 32, no. 1-2, pp. 97–102, 1996
60. Induction of Gap Junctional Communication by 4-Oxoretinoic Acid Generated from Its Precursor Canthaxanthin
    Archives of Biochemistry and Biophysics, vol. 317, no. 2, pp. 423–428, 1995
61. Efficacy of All-trans-ß-Carotene, Canthaxanthin, and All-trans, 9-cis-, and 4-Oxoretinoic Acids in Inducing Differentiation of an F9 Embryonal Carcinoma RARß-lacZ Reporter Cell Line
    Archives of Biochemistry and Biophysics, vol. 316, no. 2, pp. 665–672, 1995
62. Regulation of DNA methyltransferase during differentiation of F9 mouse embryonal carcinoma cells
    Journal of Cellular Physiology, vol. 165, no. 2, pp. 284–290, 1995
63. Exemption of Satellite DNA from Demethylation in Immortalized Differentiated Derivatives of F9 Mouse Embryonal Carcinoma Cells
    Experimental Cell Research, vol. 210, no. 2, pp. 192–200, 1994
64. Biochemistry, vol. 30, no. 25, pp. 6283–6289, 1991
65. Constitutive c-myc expression enhances proliferation of differentiating F9 teratocarcinoma cells
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1013, no. 2, pp. 125–132, 1989
66. In developing brown adipose tissue c-myc protooncogene expression is restricted to early differentiation stages
    Cell Differentiation and Development, vol. 27, no. 3, pp. 243–248, 1989
67. Albumin and ?-fetoprotein gene expression and DNA methylation in rat hepatoma cell lines
    Experimental Cell Research, vol. 174, no. 2, pp. 433–447, 1988
68. The distribution of metastases in the liver
    Virchows Archiv A Pathological Anatomy and Histology, vol. 394, no. 1-2, pp. 89–96, 1981